Voxel-based morphometry in unmedicated patients with restless legs syndrome

Sleep Medicine

Volumn 9, Issue 1, 2007, Pages 22-26

  Hornyak, Magdolna ^a   Ahrendts, Johannes C ^a   Spiegelhalder, Kai ^a   Riemann, Dieter ^a   Voderholzer, Ulrich ^a   Feige, Bernd ^a   van Elst, Ludger Tebartz ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Neuroimaging; Pathophysiology; Restless legs syndrome; Treatment; Voxel based morphometry (VBM)

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MORPHOLOGY; MORPHOMETRICS; NEUROIMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME;

ADULT; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REFERENCE VALUES; RESTLESS LEGS SYNDROME;

EID: 35948988914     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.09.010     Document Type: Article

References (17)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 4 (2003) 101-119
2. Wetter T.C., Eisensehr I., and Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med 5 4 (2004) 401-406
3. Von Spiczak S., Whone A.L., Hammers A., Asselin M.C., Turkheimer S., Tings T., et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 128 Pt 4 (2005) 906-917
4. Bucher S.F., Seelos K.C., Oertel W.H., Reiser M., and Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 41 (1997) 639-645
5. Etgen T., Draganski B., Ilg C., Schroder M., Geisler P., Hajak G., et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage 24 4 (2005) 1242-1247
6. Corson P.W., Nopoulos P., Miller D.D., Arndt S., and Andreasen N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156 8 (1999) 1200-1204
7. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
8. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001) 21-36
9. Mugler J.P.r., and Brookeman J.R. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 15 (1990) 152-157
10. Keller S.S., Wilke M., Wieshmann U.C., Sluming W.A., and Roberts N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 23 (2004) 860-868
11. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15 (2002) 870-878
12. Hagino H., Tabuchi E., Kurachi M., Saitoh O., Sun Y., Kondoh T., et al. Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging. Brain Res 813 2 (1998) 367-373
13. Bast T., and Feldon J. Hippocampal modulation of sensorimotor processes. Prog Neurobiol 70 4 (2003) 319-345
14. Hening W.A., Allen R.P., Earley C.J., Picchietti D.L., and Silber M.H. Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 560-583
15. Zornoza T., Cano-Cebrian M.J., Martinez-Garcia F., Polache A., and Granero L. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Neuropharmacology 49 7 (2005) 1067-1076
16. Zornoza T., Cano-Cebrian M.J., Miquel M., Aragon C., Polache A., and Granero L. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Neuropsychopharmacology 30 5 (2005) 843-852
17. Rule R.R., Shimamure A.P., and Knight R.T. Orbitofrontal cortex and dynamic filtering of emotional stimuli. Cogn Affect Behav Neurosci 2 3 (2002) 264-270